You are currently on the new version of our website. Access the old version .

Cancers, Volume 13, Issue 3

2021 February-1 - 223 articles

Cover Story: An interplay between estrogen receptor and growth factor signaling plays a significant role in conferring resistance to anti-estrogen therapy in estrogen receptor-positive breast cancers. Khatpe et al. provide a comprehensive review of the literature, highlighting the mechanisms associated with anti-estrogen resistance with a particular emphasis on the nexus between estrogen receptor and PI3K/AKT signaling. The authors describe how the elucidation of these mechanisms over the last three decades has resulted in the clinical testing and approval of novel drug combination therapies for estrogen receptor-positive breast cancer and better outcomes. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (223)

  • Review
  • Open Access
12 Citations
5,995 Views
24 Pages

Challenges in Crohn’s Disease Management after Gastrointestinal Cancer Diagnosis

  • Claudio Fiorillo,
  • Carlo Alberto Schena,
  • Giuseppe Quero,
  • Vito Laterza,
  • Daniela Pugliese,
  • Giuseppe Privitera,
  • Fausto Rosa,
  • Tommaso Schepis,
  • Lisa Salvatore and
  • Sergio Alfieri
  • + 6 authors

2 February 2021

Crohn’s disease (CD) is a chronic inflammatory bowel disease with a progressive course, potentially affecting the entire gastrointestinal tract from mouth to anus. Several studies have shown an increased risk of both intestinal and extra-intestinal c...

  • Article
  • Open Access
23 Citations
11,625 Views
23 Pages

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy

  • Adrián Fernández,
  • Alfonso Navarro-Zapata,
  • Adela Escudero,
  • Nerea Matamala,
  • Beatriz Ruz-Caracuel,
  • Isabel Mirones,
  • Alicia Pernas,
  • Marta Cobo,
  • Gema Casado and
  • Antonio Pérez-Martínez
  • + 9 authors

2 February 2021

Natural killer (NK) cells represent promising tools for cancer immunotherapy. We report the optimization of an NK cell activation–expansion process and its validation on clinical-scale. Methods: RPMI-1640, stem cell growth medium (SCGM), NK MACS and...

  • Article
  • Open Access
9 Citations
3,831 Views
21 Pages

Increased Expression of AKT3 in Neuroendocrine Differentiated Prostate Cancer Cells Alters the Response Towards Anti-Androgen Treatment

  • Marc Wiesehöfer,
  • Elena Dilara Czyrnik,
  • Martin Spahn,
  • Saskia Ting,
  • Henning Reis,
  • Jaroslaw Thomas Dankert and
  • Gunther Wennemuth

2 February 2021

Patients with advanced prostate carcinoma are often treated with an androgen deprivation therapy but long-term treatment can result in a metastatic castration-resistant prostate cancer. This is a more aggressive, untreatable tumor recurrence often co...

  • Article
  • Open Access
33 Citations
5,070 Views
15 Pages

Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma

  • Abraham Lin,
  • Jamoliddin Razzokov,
  • Hanne Verswyvel,
  • Angela Privat-Maldonado,
  • Joey De Backer,
  • Maksudbek Yusupov,
  • Edgar Cardenas De La Hoz,
  • Peter Ponsaerts,
  • Evelien Smits and
  • Annemie Bogaerts

2 February 2021

Non-thermal plasma (NTP) therapy has been emerging as a promising cancer treatment strategy, and recently, its ability to locally induce immunogenic cancer cell death is being unraveled. We hypothesized that the chemical species produced by NTP reduc...

  • Review
  • Open Access
31 Citations
12,181 Views
33 Pages

Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors

  • Donelle Cummings,
  • Joyce Wong,
  • Russell Palm,
  • Sarah Hoffe,
  • Khaldoun Almhanna and
  • Shivakumar Vignesh

2 February 2021

Gastric and esophageal tumors are diverse neoplasms that involve mucosal and submucosal tissue layers and include squamous cell carcinomas, adenocarcinomas, spindle cell neoplasms, neuroendocrine tumors, marginal B cell lymphomas, along with less com...

  • Review
  • Open Access
70 Citations
7,868 Views
15 Pages

Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas

  • Jeffrey I. Traylor,
  • Mark N. Pernik,
  • Alex C. Sternisha,
  • Samuel K. McBrayer and
  • Kalil G. Abdullah

2 February 2021

5-aminolevulinic acid (5-ALA) is a porphyrin precursor in the heme synthesis pathway. When supplied exogenously, certain cancers consume 5-ALA and convert it to the fluorogenic metabolite protoporphyrin IX (PpIX), causing tumor-specific tissue fluore...

  • Article
  • Open Access
14 Citations
4,412 Views
16 Pages

2 February 2021

Purpose: Prognosis for acute myeloid leukemia (AML) patients is poor, particularly in TP53 mutated AML, secondary, relapsed, and refractory AML, and in patients unfit for intensive treatment, thus highlighting an unmet need for novel therapeutic appr...

  • Guidelines
  • Open Access
20 Citations
5,172 Views
12 Pages

Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

  • Denis Horgan,
  • Gennaro Ciliberto,
  • Pierfranco Conte,
  • Giuseppe Curigliano,
  • Luis Seijo,
  • Luis M. Montuenga,
  • Marina Garassino,
  • Frederique Penault-Llorca,
  • Fabrizia Galli and
  • Ettore Capoluongo
  • + 20 authors

2 February 2021

Rapid and continuing advances in biomarker testing are not being matched by uptake in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient a...

  • Article
  • Open Access
20 Citations
5,509 Views
27 Pages

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction

  • Sofia Giacosa,
  • Catherine Pillet,
  • Irinka Séraudie,
  • Laurent Guyon,
  • Yann Wallez,
  • Caroline Roelants,
  • Christophe Battail,
  • Bertrand Evrard,
  • Frédéric Chalmel and
  • Odile Filhol
  • + 10 authors

2 February 2021

Kinase-targeted agents demonstrate antitumor activity in advanced metastatic clear cell renal cell carcinoma (ccRCC), which remains largely incurable. Integration of genomic approaches through small-molecules and genetically based high-throughput scr...

  • Review
  • Open Access
20 Citations
7,358 Views
17 Pages

The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer

  • Svetlana Miklikova,
  • Lenka Trnkova,
  • Jana Plava,
  • Martin Bohac,
  • Marcela Kuniakova and
  • Marina Cihova

2 February 2021

Taking into account the factors of high incidence rate, prevalence and mortality, breast cancer represents a crucial social and economic burden. Most cases of breast cancer develop as a consequence of somatic mutations accumulating in mammary epithel...

of 23

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694